NovaBridge Biosciences, a biotechnology company, engages in the research and development of immuno-oncology agents for the treatment of cancer in the United States. The company operates through two segments, Oncology and Ophthalmology. Its product pipeline comprises givastomig, a potential CLDN18.2...
1 insider purchase on record · latest filing 2026-04-28.
Insiders have also filed 7 sale transactions at NBP.